Mefloquine-induced disruption of calcium homeostasis in mammalian cells is similar to that induced by ionomycin

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 2, 2008, Pages 684-693

  Caridha, D ^a   Yourick, D ^a   Cabezas, M ^a   Wolf, L ^a   Hudson, T H ^a   Dow, G S ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; 2 AMINO 3 PHOSPHONOPROPIONIC ACID; 2 AMINO 4 PHOSPHONOBUTYRIC ACID; 2 AMINO 5 PHOSPHONOVALERIC ACID; 4 PHOSPHONOMETHYLPIPECOLIC ACID; 6,7 DINITRO 2,3 QUINOXALINEDIONE; ARCAINE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DANTROLENE; DIZOCILPINE; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; GUANOSINE TRIPHOSPHATE; GYKI 152466; INOSITOL PHOSPHATE; INOSITOL PHOSPHATE 3; IONOMYCIN; KAINIC ACID; MAGNESIUM; MEFLOQUINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEOMYCIN; NON NMDA ANTAGONIST; RUTHENIUM RED; SKF 93665; THAPSIGARGIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL; XESTOSPONGIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL TYPE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENDOPLASMIC RETICULUM; IN VIVO STUDY; LIGAND BINDING; MAMMAL CELL; MEMBRANE BINDING; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT;

ANIMALS; ANTIMALARIALS; CALCIUM; CELL LINE; CELLS, CULTURED; CEREBRAL CORTEX; HOMEOSTASIS; IONOMYCIN; MACROPHAGES; MEFLOQUINE; NEURONS; RATS;

EID: 38649134796     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00874-07     Document Type: Article

References (36)

1. Aarnoudse, A. L., R. H. van Schaik, J. Dieleman, M. Molokhia, M. M. van Riemsdijk, R. J. Ligthelm, D. Overbosch, I. P. van der Heiden, and B. H. Stricker. 2006. MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine. Clin. Pharmacol. Ther. 80:367-374.
2. Agus, Z. S., E. Kelepouris, I. Dukes, and M. Morad. 1989. Cytosolic magnesium modulates calcium channel activity in mammalian ventricular cells. Am. J. Physiol. 256:C452-C455.
3. Anonymous. 1996. Guide for the care and use of laboratory animals. National Research Council, Washington, DC.
4. Barraud de Lagerie, S., E. Comets, C. Gautrand, C. Fernandez, D. Auchere, E. Singlas, F. Mentre, and F. Gimenez. 2004. Cerebral uptake of mefloquine enantiomers with and without the P-gp inhibitor elacridar (GF1210918) in mice. Br. J. Pharmacol. 141:1214-1222.
5. Baudry, S., Y. T. Pham, B. Baune, S. Vidrequin, C. Crevoisier, F. Gimenez, and R. Farinotti. 1997. Stereoselective passage of mefloquine through the blood-brain barrier in the rat. J. Pharm. Pharmacol. 49:1086-1090.
6. Berridge, M. J. 1995. Capacitative calcium entry. Biochem. J. 312:1-11.
7. Bethal, V. 2006. Mode of action of microbial bioactive metabolites. Folia Microbiol. (Prague) 51:359-369.
8. Birnbaumer, L., X. Zhu, M. Jiang, G. Boulay, M. Peyton, B. Vannier, D. Brown, D. Platano, H. Sadeghi, E. Stefani, and M. Birnbaumer. 1996. On the molecular basis and regulation of cellular capacitative calcium entry: roles for Trp proteins. Proc. Natl. Acad. Sci. USA 93:15195-15202.
9. Chen, J., H. Li, C. Luo, Z. Li, and J. Zheng. 1999. Involvement of peripheral NMDA and non-NMDA receptors in development of persistent firing of spinal wide-dynamic-range neurons induced by subcutaneous bee venom injection in the cat. Brain Res. 844:98-105.
10. Chevli, R., and C. D. Fitch. 1982. The antimalarial drug mefloquine binds to membrane phospholipids. Antimicrob. Agents Chemother. 21:581-586.
11. Degani, H., S. Simon, and A. C. McLaughlin. 1981. The kinetics of ionophore X-537A-mediated transport of manganese through dipalmitoylphosphatidylcholine vesicles. A 1H-NMR study. Biochim. Biophys. Acta 646:320-328.
12. Dow, G., R. Bauman, D. Caridha, M. Cabezas, F. Du, R. Gomez-Lobo, M. Park, K. Smith, and K. Cannard. 2006. Mefloquine induces dose-related neurological effects in a rat model. Antimicrob. Agents Chemother. 50:1045-1053.
13. Dow, G. S., D. Caridha, M. Goldberg, L. Wolf, M. L. Koenig, D. L. Yourick, and Z. Wang. 2005. Transcriptional profiling of mefloquine-induced disruption of calcium homeostasis in neurons in vitro. Genomics 86:539-550.
14. Dow, G. S., T. H. Hudson, M. Vahey, and M. L. Koenig. 2003. The acute neurotoxicity of mefloquine may be mediated through a disruption of calcium homeostasis and ER function in vitro. Malar. J. 2:14.
15. Erdahl, W. L., C. J. Chapman, R. W. Taylor, and D. R. Pfeiffer. 1994. Ca2+ transport properties of ionophores A23187, ionomycin, and 4-BrA23187 in a well defined model system. Biophys. J. 66:1678-1693.
16. Go, M. L., and T. L. Ngiam. 1997. Thermodynamics of partitioning of the antimalarial drug mefloquine in phospholipid bilayers and bulk solvents. Chem. Pharm. Bull. (Tokyo) 45:2055-2060.
17. Hildebrandt, J. P., T. D. Plant, and H. Meves. 1997. The effects of bradykinin on K+ currents in NG108-15 cells treated with U73122, a phospholipase C inhibitor, or neomycin. Br. J. Pharmacol. 120:841-850.
18. Jones, R., G. Kunsman, B. Levine, M. Smith, and C. Stahl. 1994. Mefloquine distribution in postmortem cases. Forensic Sci. Int. 68:29-32.
19. Kiselyov, K., D. M. Shin, N. Shcheynikov, T. Kurosaki, and S. Muallem. 2001. Regulation of Ca2+-release-activated Ca2+ current (Icrac) by ryanodine receptors in inositol 1,4,5-trisphosphate-receptor-deficient DT40 cells. Biochem. J. 360:17-22.
20. 2 (EEP). Peptides 22:2091-2097.
21. Martinez, J. R., S. Willis, S. Puente, J. Wells, R. Helmke, and G. H. Zhang. 1996. Evidence for a Ca2+ pool associated with secretory granules in rat submandibular acinar cells. Biochem. J. 320:627-634.
22. Matsuzaki, K., S. Nakai, T. Handa, Y. Takaishi, T. Fujita, and K. Miyajima. 1989. Hypelcin A, an alpha-aminoisobutyric acid containing antibiotic peptide, induced permeability change of phosphatidylcholine bilayers. Biochemistry 28:9392-9398.
23. Morgan, A. J., and R. Jacob. 1994. Ionomycin enhances Ca2+ influx by stimulating store-regulated cation entry and not by a direct action at the plasma membrane. Biochem. J. 300:665-672.
24. Myles, M. 1994. Carbachol, but not norepinephrine, NMDA, ionomycin, ouabain, or phorbol myristate acetate, increases inositol 1,3,4,5-tetrakisphosphate accumulation in rat brain cortical slices. J. Neurochem. 62:2333.
25. Pham, Y. T., F. Nosten, R. Farinotti, N. J. White, and F. Gimenez. 1999. Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria. Int. J. Clin. Pharmacol. Ther. 37:58-61.
26. Phillips-Howard, P. A., and F. O. ter Kuile. 1995. CNS adverse events associated with antimalarial agents. Fact or fiction? Drug Saf. 12:370-383.
27. Putney, J. W., Jr. 2001. Pharmacology of capacitative calcium entry. Mol. Interv. 1:84-94.
28. Ramos, H., A. Attias de Murciano, B. E. Cohen, and J. Bolard. 1989. The polyene antibiotic amphotericin B acts as a Ca2+ ionophore in sterol-containing liposomes. Biochim. Biophys. Acta 982:303-306.
29. Rosenthal, W., J. Hescheler, W. Trautwein, and G. Schultz. 1988. Control of voltage-dependent Ca2+ channels by G protein-coupled receptors. FASEB J. 2:2784-2790.
30. Schlagenhauf, P. 1999. Mefloquine for malaria chemoprophylaxis 1992-1998: a review. J. Travel Med. 6:122-133.
31. Taylor, S. C., and C. Peers. 1999. Store-operated Ca2+ influx and voltage-gated Ca2+ channels coupled to exocytosis in pheochromocytoma (PC12) cells. J. Neurochem. 73:874-880.
32. Wang, E., W. L. Erdahl, S. A. Hamidinia, C. J. Chapman, R. W. Taylor, and D. R. Pfeiffer. 2001. Transport properties of the calcium ionophore ETH-129. Biophys. J. 81:3275-3284.
33. Yang, C. M., S. P. Chou, Y. Y. Wang, J. T. Hsieh, and R. Ong. 1993. Muscarinic regulation of cytosolic free calcium in canine tracheal smooth muscle cells: Ca2+ requirement for phospholipase C activation. Br. J. Pharmacol. 110:1239-1247.
34. Yoshida, S., and S. Plant. 1992. Mechanism of release of Ca2+ from intracellular stores in response to ionomycin in oocytes of the frog Xenopus laevis. J. Physiol. 458:307-318.
35. Yourick, D. L., M. C. LaPlaca, and J. L. Meyerhoff. 1991. Norepinephrine-stimulated phosphatidylinositol metabolism in genetically epilepsy-prone and kindled rats. Brain Res. 551:315-318.
36. Zidovetzki, R., I. W. Sherman, A. Atiya, and H. De Boeck. 1989. A nuclear magnetic resonance study of the interactions of the antimalarials chloroquine, quinacrine, quinine and mefloquine with dipalmitoylphosphatidylcholine bilayers. Mol. Biochem. Parasitol. 35:199-207.